

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.09632724 |
| 2 | proteasome assembly (GO:0043248) | 4.37510704 |
| 3 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.25442603 |
| 4 | protein carboxylation (GO:0018214) | 4.25442603 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.11006619 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.11006619 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 3.99506837 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.99506837 |
| 9 | sequestering of actin monomers (GO:0042989) | 3.73109472 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 3.69755239 |
| 11 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.50809223 |
| 12 | regulation of cholesterol esterification (GO:0010872) | 3.38480699 |
| 13 | cellular response to interferon-beta (GO:0035458) | 3.36627573 |
| 14 | reverse cholesterol transport (GO:0043691) | 3.35613308 |
| 15 | regulation of mitochondrial translation (GO:0070129) | 3.33642393 |
| 16 | regulation of fibrinolysis (GO:0051917) | 3.24011675 |
| 17 | L-serine metabolic process (GO:0006563) | 3.20989079 |
| 18 | formation of translation preinitiation complex (GO:0001731) | 3.14119765 |
| 19 | plasma lipoprotein particle assembly (GO:0034377) | 3.12496272 |
| 20 | serine family amino acid biosynthetic process (GO:0009070) | 3.11013213 |
| 21 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.10956740 |
| 22 | regulation of plasminogen activation (GO:0010755) | 3.10792637 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 3.10471732 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.04022379 |
| 25 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03191709 |
| 26 | protein-lipid complex remodeling (GO:0034368) | 3.03191709 |
| 27 | macromolecular complex remodeling (GO:0034367) | 3.03191709 |
| 28 | response to interferon-beta (GO:0035456) | 3.01807722 |
| 29 | glycine metabolic process (GO:0006544) | 3.00358305 |
| 30 | cholesterol efflux (GO:0033344) | 2.99002214 |
| 31 | ribosomal small subunit assembly (GO:0000028) | 2.98791286 |
| 32 | response to peptidoglycan (GO:0032494) | 2.98705498 |
| 33 | intestinal cholesterol absorption (GO:0030299) | 2.96580121 |
| 34 | negative regulation of viral genome replication (GO:0045071) | 2.96437761 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.95518284 |
| 36 | ribosome biogenesis (GO:0042254) | 2.92381391 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.90651348 |
| 38 | nephron epithelium morphogenesis (GO:0072088) | 2.90471653 |
| 39 | nephron tubule morphogenesis (GO:0072078) | 2.90471653 |
| 40 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.90408042 |
| 41 | 4-hydroxyproline metabolic process (GO:0019471) | 2.89201941 |
| 42 | regulation of protein activation cascade (GO:2000257) | 2.86814918 |
| 43 | proline metabolic process (GO:0006560) | 2.86250208 |
| 44 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.84810193 |
| 45 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.82974042 |
| 46 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.82974042 |
| 47 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.82974042 |
| 48 | positive regulation of actin filament depolymerization (GO:0030836) | 2.79604605 |
| 49 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.79545634 |
| 50 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.79545634 |
| 51 | peptidyl-histidine modification (GO:0018202) | 2.79402724 |
| 52 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.77097061 |
| 53 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.75568613 |
| 54 | protein-lipid complex assembly (GO:0065005) | 2.74350533 |
| 55 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.73644791 |
| 56 | DNA double-strand break processing (GO:0000729) | 2.73388741 |
| 57 | regulation of complement activation (GO:0030449) | 2.72982800 |
| 58 | response to interferon-alpha (GO:0035455) | 2.72792985 |
| 59 | proline biosynthetic process (GO:0006561) | 2.72305908 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.72187075 |
| 61 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.71871817 |
| 62 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.71871817 |
| 63 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.71295188 |
| 64 | negative regulation of lipase activity (GO:0060192) | 2.69852507 |
| 65 | regulation of translational fidelity (GO:0006450) | 2.69547048 |
| 66 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.69480815 |
| 67 | maturation of 5.8S rRNA (GO:0000460) | 2.68706379 |
| 68 | cullin deneddylation (GO:0010388) | 2.66157014 |
| 69 | positive regulation of T cell chemotaxis (GO:0010820) | 2.65943259 |
| 70 | regulation of T cell chemotaxis (GO:0010819) | 2.65943259 |
| 71 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.65712690 |
| 72 | positive regulation of defense response to virus by host (GO:0002230) | 2.64888856 |
| 73 | B cell mediated immunity (GO:0019724) | 2.59796224 |
| 74 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.59024396 |
| 75 | negative regulation of ligase activity (GO:0051352) | 2.59024396 |
| 76 | neutrophil activation involved in immune response (GO:0002283) | 2.58634149 |
| 77 | triglyceride homeostasis (GO:0070328) | 2.57492924 |
| 78 | acylglycerol homeostasis (GO:0055090) | 2.57492924 |
| 79 | tetrahydrofolate metabolic process (GO:0046653) | 2.57106809 |
| 80 | protein deneddylation (GO:0000338) | 2.55742612 |
| 81 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55471320 |
| 82 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.54545046 |
| 83 | nephron tubule formation (GO:0072079) | 2.53959484 |
| 84 | base-excision repair, AP site formation (GO:0006285) | 2.53500070 |
| 85 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.53483893 |
| 86 | regulation of activation of Janus kinase activity (GO:0010533) | 2.53466477 |
| 87 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.53019684 |
| 88 | termination of RNA polymerase III transcription (GO:0006386) | 2.53019684 |
| 89 | type I interferon signaling pathway (GO:0060337) | 2.51890533 |
| 90 | cellular response to type I interferon (GO:0071357) | 2.51890533 |
| 91 | blood coagulation, intrinsic pathway (GO:0007597) | 2.50735616 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.48648477 |
| 93 | positive regulation of cell cycle arrest (GO:0071158) | 2.47799504 |
| 94 | response to type I interferon (GO:0034340) | 2.47630001 |
| 95 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.47603116 |
| 96 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.47567290 |
| 97 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.47534728 |
| 98 | polyketide metabolic process (GO:0030638) | 2.47244113 |
| 99 | doxorubicin metabolic process (GO:0044598) | 2.47244113 |
| 100 | daunorubicin metabolic process (GO:0044597) | 2.47244113 |
| 101 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.46276641 |
| 102 | plasma lipoprotein particle clearance (GO:0034381) | 2.45287619 |
| 103 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.43942048 |
| 104 | serine family amino acid metabolic process (GO:0009069) | 2.43130510 |
| 105 | cellular response to interferon-alpha (GO:0035457) | 2.42023207 |
| 106 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.40996876 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 2.40336477 |
| 108 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.40227728 |
| 109 | aldehyde catabolic process (GO:0046185) | 2.39694725 |
| 110 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.39393754 |
| 111 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.37239944 |
| 112 | positive regulation of ligase activity (GO:0051351) | 2.37022340 |
| 113 | DNA replication checkpoint (GO:0000076) | 2.36498017 |
| 114 | ribosomal large subunit biogenesis (GO:0042273) | 2.35385855 |
| 115 | cochlea morphogenesis (GO:0090103) | 2.35373202 |
| 116 | kidney mesenchyme development (GO:0072074) | 2.34928901 |
| 117 | phospholipid efflux (GO:0033700) | 2.34337397 |
| 118 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.33658287 |
| 119 | telomere maintenance via recombination (GO:0000722) | 2.32666310 |
| 120 | serine family amino acid catabolic process (GO:0009071) | 2.32051564 |
| 121 | endosome to pigment granule transport (GO:0043485) | 2.31890762 |
| 122 | endosome to melanosome transport (GO:0035646) | 2.31890762 |
| 123 | regulation of RIG-I signaling pathway (GO:0039535) | 2.31827311 |
| 124 | NIK/NF-kappaB signaling (GO:0038061) | 2.30216064 |
| 125 | 7-methylguanosine mRNA capping (GO:0006370) | 2.29490008 |
| 126 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.29414636 |
| 127 | cellular response to exogenous dsRNA (GO:0071360) | 2.29270670 |
| 128 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.28177031 |
| 129 | DNA strand renaturation (GO:0000733) | 2.27842930 |
| 130 | pattern specification involved in kidney development (GO:0061004) | 2.27166916 |
| 131 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.27002225 |
| 132 | regulation of T-helper 1 type immune response (GO:0002825) | 2.24938847 |
| 133 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.24644975 |
| 134 | DNA strand elongation (GO:0022616) | 2.24622632 |
| 135 | positive regulation of viral genome replication (GO:0045070) | 2.24189974 |
| 136 | protein-lipid complex subunit organization (GO:0071825) | 2.23903031 |
| 137 | positive regulation of interleukin-12 production (GO:0032735) | 2.23198509 |
| 138 | 7-methylguanosine RNA capping (GO:0009452) | 2.22903033 |
| 139 | RNA capping (GO:0036260) | 2.22903033 |
| 140 | pseudouridine synthesis (GO:0001522) | 2.22881713 |
| 141 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.22653567 |
| 142 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.22039260 |
| 143 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.21666373 |
| 144 | cell cycle G1/S phase transition (GO:0044843) | 2.21666373 |
| 145 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.21502736 |
| 146 | DNA demethylation (GO:0080111) | 2.21390042 |
| 147 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.21112883 |
| 148 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.20797075 |
| 149 | natural killer cell mediated immunity (GO:0002228) | 2.20797075 |
| 150 | dendritic cell chemotaxis (GO:0002407) | 2.20368927 |
| 151 | maturation of SSU-rRNA (GO:0030490) | 2.20077509 |
| 152 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.19840480 |
| 153 | basement membrane organization (GO:0071711) | 2.19701392 |
| 154 | positive regulation of T cell migration (GO:2000406) | 2.19533121 |
| 155 | protein maturation by protein folding (GO:0022417) | 2.18578782 |
| 156 | regulation of protein heterodimerization activity (GO:0043497) | 2.18321316 |
| 157 | immunoglobulin mediated immune response (GO:0016064) | 2.17718595 |
| 158 | metanephric mesenchyme development (GO:0072075) | 2.17528358 |
| 159 | regulation of viral genome replication (GO:0045069) | 2.17383484 |
| 160 | leukocyte aggregation (GO:0070486) | 2.16521415 |
| 161 | heterochromatin organization (GO:0070828) | 2.16319159 |
| 162 | aromatic amino acid family catabolic process (GO:0009074) | 2.15765410 |
| 163 | mitotic metaphase plate congression (GO:0007080) | 2.14775642 |
| 164 | negative regulation of cholesterol transport (GO:0032375) | 2.13029683 |
| 165 | negative regulation of sterol transport (GO:0032372) | 2.13029683 |
| 166 | outer ear morphogenesis (GO:0042473) | 2.12204759 |
| 167 | peptidyl-proline hydroxylation (GO:0019511) | 2.11671185 |
| 168 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.10742748 |
| 169 | pteridine-containing compound metabolic process (GO:0042558) | 2.10659284 |
| 170 | fibrinolysis (GO:0042730) | 2.09929481 |
| 171 | L-ascorbic acid metabolic process (GO:0019852) | 2.09597167 |
| 172 | organ induction (GO:0001759) | 2.07843497 |
| 173 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.05535041 |
| 174 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.05312762 |
| 175 | fatty acid homeostasis (GO:0055089) | 2.04746913 |
| 176 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.03100739 |
| 177 | positive regulation of hormone metabolic process (GO:0032352) | 2.02747964 |
| 178 | renal tubule morphogenesis (GO:0061333) | 2.02009572 |
| 179 | cranial nerve morphogenesis (GO:0021602) | 2.00644442 |
| 180 | glomerular basement membrane development (GO:0032836) | 2.00106247 |
| 181 | ventricular cardiac muscle cell development (GO:0055015) | 2.00098301 |
| 182 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.98900565 |
| 183 | endothelial cell morphogenesis (GO:0001886) | 1.98690044 |
| 184 | paraxial mesoderm development (GO:0048339) | 1.97469735 |
| 185 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 1.96378459 |
| 186 | cholesterol homeostasis (GO:0042632) | 1.94376415 |
| 187 | mitotic sister chromatid segregation (GO:0000070) | 1.94345590 |
| 188 | branched-chain amino acid catabolic process (GO:0009083) | 1.93399703 |
| 189 | positive regulation of mesonephros development (GO:0061213) | 1.93174065 |
| 190 | glutamate metabolic process (GO:0006536) | 1.92334623 |
| 191 | folic acid-containing compound metabolic process (GO:0006760) | 1.91766121 |
| 192 | protein hydroxylation (GO:0018126) | 1.91480580 |
| 193 | regulation of apoptotic cell clearance (GO:2000425) | 1.91214790 |
| 194 | sterol homeostasis (GO:0055092) | 1.91103671 |
| 195 | alpha-amino acid catabolic process (GO:1901606) | 1.90102599 |
| 196 | gluconeogenesis (GO:0006094) | 1.90028754 |
| 197 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 1.89506303 |
| 198 | glyoxylate metabolic process (GO:0046487) | 1.87175721 |
| 199 | peptidyl-glutamic acid modification (GO:0018200) | 1.87095996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.72627188 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.19048364 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.50436246 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.40539816 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.21246833 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.14259173 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.08348456 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.00446477 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.00384043 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.96507619 |
| 11 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.81700750 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.73334771 |
| 13 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.68694049 |
| 14 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.55932348 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.49712460 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.47487167 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46324881 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.35468319 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.33074962 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.24006502 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.23741877 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.21571757 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.18893667 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.17934552 |
| 25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14901295 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.13890063 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.05463390 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.04390220 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04354570 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.04216785 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.99639919 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99556453 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.95102057 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.87842861 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.87715105 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.87471010 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87416884 |
| 38 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86343645 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85917552 |
| 40 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.85582675 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.81255021 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.80641040 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.79825472 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.78398440 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74274673 |
| 46 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.72804979 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71226329 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.70835884 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70660221 |
| 50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.69274393 |
| 51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.68356666 |
| 52 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68160419 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.67136172 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66952404 |
| 55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.66552755 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66429538 |
| 57 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.65592626 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65338533 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63840279 |
| 60 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63699505 |
| 61 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.63610672 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.61917197 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.61743164 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.60887151 |
| 65 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.59983053 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.56632036 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.55465751 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.54189584 |
| 69 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54085579 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53700903 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47707760 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42155208 |
| 73 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40083073 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39223274 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38992370 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38560219 |
| 77 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36682816 |
| 78 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35444363 |
| 79 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34248430 |
| 80 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33678282 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33047808 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32789009 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31836016 |
| 84 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.27785254 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27397548 |
| 86 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26984797 |
| 87 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.26910174 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25252543 |
| 89 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.24376477 |
| 90 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23901229 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21960634 |
| 92 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21497907 |
| 93 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20688053 |
| 94 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.19826969 |
| 95 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18107890 |
| 96 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17531437 |
| 97 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12952073 |
| 98 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.12806358 |
| 99 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11577735 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10691342 |
| 101 | MYB_26560356_Chip-Seq_TH2_Human | 1.09840267 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08647549 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08574030 |
| 104 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.08142566 |
| 105 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08138496 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07993946 |
| 107 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07309168 |
| 108 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04715140 |
| 109 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04715140 |
| 110 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04715140 |
| 111 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01649726 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01424903 |
| 113 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00903318 |
| 114 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00857022 |
| 115 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99709520 |
| 116 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99535734 |
| 117 | MYB_26560356_Chip-Seq_TH1_Human | 0.99491483 |
| 118 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99045821 |
| 119 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.98898249 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98300630 |
| 121 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97206480 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96633125 |
| 123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96400504 |
| 124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95662104 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95594529 |
| 126 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95524746 |
| 127 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95350515 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95122956 |
| 129 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94492405 |
| 130 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94181015 |
| 131 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94015241 |
| 132 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93887466 |
| 133 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93761788 |
| 134 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93722031 |
| 135 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93602824 |
| 136 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92749973 |
| 137 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92241520 |
| 138 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91776611 |
| 139 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.91739383 |
| 140 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91701669 |
| 141 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90007477 |
| 142 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89975653 |
| 143 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.89853336 |
| 144 | MYC_22102868_ChIP-Seq_BL_Human | 0.89764285 |
| 145 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.89513320 |
| 146 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.89335161 |
| 147 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88792799 |
| 148 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88114693 |
| 149 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.85668900 |
| 150 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84849785 |
| 151 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83477757 |
| 152 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.83385562 |
| 153 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82661034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.20364464 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.11733750 |
| 3 | MP0003693_abnormal_embryo_hatching | 2.83128072 |
| 4 | MP0000685_abnormal_immune_system | 2.66879330 |
| 5 | MP0004272_abnormal_basement_membrane | 2.53795500 |
| 6 | MP0005360_urolithiasis | 2.53663354 |
| 7 | MP0009785_altered_susceptibility_to | 2.50801206 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.47390948 |
| 9 | MP0008058_abnormal_DNA_repair | 2.40815890 |
| 10 | MP0005671_abnormal_response_to | 2.30985019 |
| 11 | MP0003195_calcinosis | 2.21561482 |
| 12 | MP0008057_abnormal_DNA_replication | 2.20027920 |
| 13 | MP0003436_decreased_susceptibility_to | 2.19754210 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.18877664 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.05895671 |
| 16 | MP0003077_abnormal_cell_cycle | 1.96124232 |
| 17 | MP0010094_abnormal_chromosome_stability | 1.95502580 |
| 18 | MP0005000_abnormal_immune_tolerance | 1.92245079 |
| 19 | MP0003763_abnormal_thymus_physiology | 1.90792119 |
| 20 | MP0010030_abnormal_orbit_morphology | 1.88943672 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.88741411 |
| 22 | MP0003786_premature_aging | 1.84433860 |
| 23 | MP0003111_abnormal_nucleus_morphology | 1.83570074 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 1.81648003 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.81591263 |
| 26 | MP0003122_maternal_imprinting | 1.80226174 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.79216809 |
| 28 | MP0005365_abnormal_bile_salt | 1.77073049 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.76017039 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.73318227 |
| 31 | MP0003283_abnormal_digestive_organ | 1.70240125 |
| 32 | MP0002249_abnormal_larynx_morphology | 1.69624331 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.67277922 |
| 34 | MP0001661_extended_life_span | 1.67158833 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.64491413 |
| 36 | MP0005025_abnormal_response_to | 1.63766086 |
| 37 | MP0000003_abnormal_adipose_tissue | 1.63469461 |
| 38 | MP0005332_abnormal_amino_acid | 1.63360424 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.62316071 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.60159549 |
| 41 | MP0002723_abnormal_immune_serum | 1.59962659 |
| 42 | MP0001790_abnormal_immune_system | 1.58428433 |
| 43 | MP0005387_immune_system_phenotype | 1.58428433 |
| 44 | MP0004957_abnormal_blastocyst_morpholog | 1.56343116 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.55791371 |
| 46 | MP0001819_abnormal_immune_cell | 1.54443796 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.54273396 |
| 48 | MP0000858_altered_metastatic_potential | 1.54096598 |
| 49 | MP0005503_abnormal_tendon_morphology | 1.53876507 |
| 50 | MP0008932_abnormal_embryonic_tissue | 1.53265337 |
| 51 | MP0001853_heart_inflammation | 1.52340068 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.52061394 |
| 53 | MP0000566_synostosis | 1.51882944 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.51856652 |
| 55 | MP0001800_abnormal_humoral_immune | 1.50715075 |
| 56 | MP0002419_abnormal_innate_immunity | 1.50212796 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.47827194 |
| 58 | MP0009697_abnormal_copulation | 1.46889486 |
| 59 | MP0003724_increased_susceptibility_to | 1.46311939 |
| 60 | MP0002405_respiratory_system_inflammati | 1.44408985 |
| 61 | MP0003937_abnormal_limbs/digits/tail_de | 1.43327567 |
| 62 | MP0002398_abnormal_bone_marrow | 1.43236251 |
| 63 | MP0000678_abnormal_parathyroid_gland | 1.41651617 |
| 64 | MP0002132_abnormal_respiratory_system | 1.41556563 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.40115664 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.39543422 |
| 67 | MP0003941_abnormal_skin_development | 1.35417654 |
| 68 | MP0002697_abnormal_eye_size | 1.32870546 |
| 69 | MP0003385_abnormal_body_wall | 1.29574879 |
| 70 | MP0003136_yellow_coat_color | 1.28141913 |
| 71 | MP0005623_abnormal_meninges_morphology | 1.27967155 |
| 72 | MP0000490_abnormal_crypts_of | 1.27966734 |
| 73 | MP0003315_abnormal_perineum_morphology | 1.25773383 |
| 74 | MP0000716_abnormal_immune_system | 1.25274435 |
| 75 | MP0003279_aneurysm | 1.24915111 |
| 76 | MP0001299_abnormal_eye_distance/ | 1.22228292 |
| 77 | MP0003252_abnormal_bile_duct | 1.20869950 |
| 78 | MP0005408_hypopigmentation | 1.19268056 |
| 79 | MP0005085_abnormal_gallbladder_physiolo | 1.19082095 |
| 80 | MP0005023_abnormal_wound_healing | 1.19050792 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.14370737 |
| 82 | MP0001545_abnormal_hematopoietic_system | 1.14370737 |
| 83 | MP0006082_CNS_inflammation | 1.13970435 |
| 84 | MP0000534_abnormal_ureter_morphology | 1.13678798 |
| 85 | MP0001542_abnormal_bone_strength | 1.12291504 |
| 86 | MP0002722_abnormal_immune_system | 1.11727786 |
| 87 | MP0002163_abnormal_gland_morphology | 1.11715981 |
| 88 | MP0003186_abnormal_redox_activity | 1.11204201 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 1.10367425 |
| 90 | MP0000703_abnormal_thymus_morphology | 1.10172602 |
| 91 | MP0002233_abnormal_nose_morphology | 1.10038796 |
| 92 | MP0002429_abnormal_blood_cell | 1.09777058 |
| 93 | MP0009840_abnormal_foam_cell | 1.08598884 |
| 94 | MP0010307_abnormal_tumor_latency | 1.07310267 |
| 95 | MP0001270_distended_abdomen | 1.06876440 |
| 96 | MP0000639_abnormal_adrenal_gland | 1.06688098 |
| 97 | MP0000689_abnormal_spleen_morphology | 1.05998752 |
| 98 | MP0002933_joint_inflammation | 1.05679618 |
| 99 | MP0001286_abnormal_eye_development | 1.05002258 |
| 100 | MP0003755_abnormal_palate_morphology | 1.04808984 |
| 101 | MP0004133_heterotaxia | 1.03521959 |
| 102 | MP0001119_abnormal_female_reproductive | 1.01789561 |
| 103 | MP0002019_abnormal_tumor_incidence | 1.01469203 |
| 104 | MP0005187_abnormal_penis_morphology | 1.00711659 |
| 105 | MP0002160_abnormal_reproductive_system | 1.00403525 |
| 106 | MP0009384_cardiac_valve_regurgitation | 1.00386820 |
| 107 | MP0003448_altered_tumor_morphology | 0.99266385 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.98603440 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.98504582 |
| 110 | MP0005670_abnormal_white_adipose | 0.98303315 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.97670138 |
| 112 | MP0005084_abnormal_gallbladder_morpholo | 0.97518166 |
| 113 | MP0000350_abnormal_cell_proliferation | 0.97361600 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.96656370 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.95755882 |
| 116 | MP0005310_abnormal_salivary_gland | 0.94663605 |
| 117 | MP0010155_abnormal_intestine_physiology | 0.94426480 |
| 118 | MP0005390_skeleton_phenotype | 0.94353231 |
| 119 | MP0004233_abnormal_muscle_weight | 0.94329273 |
| 120 | MP0009250_abnormal_appendicular_skeleto | 0.94218193 |
| 121 | MP0001293_anophthalmia | 0.92925592 |
| 122 | MP0002932_abnormal_joint_morphology | 0.92880026 |
| 123 | MP0001666_abnormal_nutrient_absorption | 0.92416817 |
| 124 | MP0000762_abnormal_tongue_morphology | 0.92178633 |
| 125 | MP0005171_absent_coat_pigmentation | 0.90740488 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.90056535 |
| 127 | MP0001879_abnormal_lymphatic_vessel | 0.89854954 |
| 128 | MP0005075_abnormal_melanosome_morpholog | 0.89811854 |
| 129 | MP0000015_abnormal_ear_pigmentation | 0.89332547 |
| 130 | MP0001346_abnormal_lacrimal_gland | 0.89080740 |
| 131 | MP0001944_abnormal_pancreas_morphology | 0.87166630 |
| 132 | MP0000313_abnormal_cell_death | 0.87020163 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.85837925 |
| 134 | MP0008789_abnormal_olfactory_epithelium | 0.84162744 |
| 135 | MP0002006_tumorigenesis | 0.83378635 |
| 136 | MP0004947_skin_inflammation | 0.82905115 |
| 137 | MP0005275_abnormal_skin_tensile | 0.82692410 |
| 138 | MP0000681_abnormal_thyroid_gland | 0.82545513 |
| 139 | MP0005375_adipose_tissue_phenotype | 0.82283040 |
| 140 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82069460 |
| 141 | MP0000049_abnormal_middle_ear | 0.81254096 |
| 142 | MP0008995_early_reproductive_senescence | 0.80545235 |
| 143 | MP0003119_abnormal_digestive_system | 0.80293562 |
| 144 | MP0009053_abnormal_anal_canal | 0.79636735 |
| 145 | MP0003868_abnormal_feces_composition | 0.79429991 |
| 146 | MP0001764_abnormal_homeostasis | 0.79162923 |
| 147 | MP0001958_emphysema | 0.79040378 |
| 148 | MP0003935_abnormal_craniofacial_develop | 0.77555788 |
| 149 | MP0002108_abnormal_muscle_morphology | 0.77118279 |
| 150 | MP0005389_reproductive_system_phenotype | 0.76965310 |
| 151 | MP0003879_abnormal_hair_cell | 0.76593740 |
| 152 | MP0002114_abnormal_axial_skeleton | 0.76213915 |
| 153 | MP0004782_abnormal_surfactant_physiolog | 0.75942249 |
| 154 | MP0002938_white_spotting | 0.75664708 |
| 155 | MP0003115_abnormal_respiratory_system | 0.75596730 |
| 156 | MP0001756_abnormal_urination | 0.75563017 |
| 157 | MP0002210_abnormal_sex_determination | 0.75494155 |
| 158 | MP0002234_abnormal_pharynx_morphology | 0.75152974 |
| 159 | MP0001243_abnormal_dermal_layer | 0.74975591 |
| 160 | MP0002092_abnormal_eye_morphology | 0.73748045 |
| 161 | MP0002085_abnormal_embryonic_tissue | 0.73517769 |
| 162 | MP0002111_abnormal_tail_morphology | 0.73161976 |
| 163 | MP0000627_abnormal_mammary_gland | 0.73141525 |
| 164 | MP0005508_abnormal_skeleton_morphology | 0.72644512 |
| 165 | MP0002282_abnormal_trachea_morphology | 0.72534928 |
| 166 | MP0002116_abnormal_craniofacial_bone | 0.72069368 |
| 167 | MP0004197_abnormal_fetal_growth/weight/ | 0.71411549 |
| 168 | MP0000371_diluted_coat_color | 0.71040043 |
| 169 | MP0002751_abnormal_autonomic_nervous | 0.70365625 |
| 170 | MP0003123_paternal_imprinting | 0.70284291 |
| 171 | MP0000516_abnormal_urinary_system | 0.69287384 |
| 172 | MP0005367_renal/urinary_system_phenotyp | 0.69287384 |
| 173 | MP0000462_abnormal_digestive_system | 0.69147826 |
| 174 | MP0003942_abnormal_urinary_system | 0.69018562 |
| 175 | MP0002254_reproductive_system_inflammat | 0.68810280 |
| 176 | MP0000428_abnormal_craniofacial_morphol | 0.68678655 |
| 177 | MP0003950_abnormal_plasma_membrane | 0.68535658 |
| 178 | MP0001697_abnormal_embryo_size | 0.68388803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.15256774 |
| 2 | Increased IgM level (HP:0003496) | 4.11342402 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 3.82531491 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 3.81224763 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.79143653 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.63038514 |
| 7 | Microretrognathia (HP:0000308) | 3.26151836 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.25209609 |
| 9 | Biconcave vertebral bodies (HP:0004586) | 3.17822044 |
| 10 | Chromsome breakage (HP:0040012) | 3.13845088 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11802436 |
| 12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.02530098 |
| 13 | Distal arthrogryposis (HP:0005684) | 2.90709736 |
| 14 | 11 pairs of ribs (HP:0000878) | 2.90676732 |
| 15 | Recurrent abscess formation (HP:0002722) | 2.86453740 |
| 16 | Eczematoid dermatitis (HP:0000976) | 2.85725983 |
| 17 | Hypolipoproteinemia (HP:0010981) | 2.85558106 |
| 18 | Myositis (HP:0100614) | 2.85107857 |
| 19 | Abnormality of dentin (HP:0010299) | 2.84597137 |
| 20 | Abnormality of the anterior horn cell (HP:0006802) | 2.76691688 |
| 21 | Degeneration of anterior horn cells (HP:0002398) | 2.76691688 |
| 22 | Type 2 muscle fiber atrophy (HP:0003554) | 2.73987657 |
| 23 | Cleft eyelid (HP:0000625) | 2.69761862 |
| 24 | Optic nerve coloboma (HP:0000588) | 2.68454509 |
| 25 | Trismus (HP:0000211) | 2.63435470 |
| 26 | Thrombocytosis (HP:0001894) | 2.60062257 |
| 27 | Vascular calcification (HP:0004934) | 2.52890075 |
| 28 | Birth length less than 3rd percentile (HP:0003561) | 2.45560810 |
| 29 | Muscle fiber atrophy (HP:0100295) | 2.45312028 |
| 30 | Breech presentation (HP:0001623) | 2.42292279 |
| 31 | Selective tooth agenesis (HP:0001592) | 2.41782756 |
| 32 | Cardiovascular calcification (HP:0011915) | 2.40971889 |
| 33 | Poor head control (HP:0002421) | 2.39478027 |
| 34 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.36968640 |
| 35 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.36968640 |
| 36 | Late onset (HP:0003584) | 2.36818419 |
| 37 | Orchitis (HP:0100796) | 2.34486388 |
| 38 | Joint hemorrhage (HP:0005261) | 2.34079298 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.32133635 |
| 40 | Spinal cord lesions (HP:0100561) | 2.28083407 |
| 41 | Syringomyelia (HP:0003396) | 2.28083407 |
| 42 | Reticulocytopenia (HP:0001896) | 2.23709417 |
| 43 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.23412780 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.22360070 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.22033952 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.21277679 |
| 47 | Hypoglycemic coma (HP:0001325) | 2.19952045 |
| 48 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.19833091 |
| 49 | Transposition of the great arteries (HP:0001669) | 2.19753487 |
| 50 | Abnormal connection of the cardiac segments (HP:0011545) | 2.19753487 |
| 51 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.19753487 |
| 52 | Abnormality of glycolysis (HP:0004366) | 2.18337320 |
| 53 | Patellar aplasia (HP:0006443) | 2.16158575 |
| 54 | Premature rupture of membranes (HP:0001788) | 2.16077104 |
| 55 | Optic neuritis (HP:0100653) | 2.14761614 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.14761614 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.14081929 |
| 58 | Gout (HP:0001997) | 2.11461106 |
| 59 | Coronal craniosynostosis (HP:0004440) | 2.09586338 |
| 60 | IgA deficiency (HP:0002720) | 2.08950322 |
| 61 | Nuclear cataract (HP:0100018) | 2.07263442 |
| 62 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.07233825 |
| 63 | Premature graying of hair (HP:0002216) | 2.06363265 |
| 64 | Meckel diverticulum (HP:0002245) | 2.05178674 |
| 65 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05065526 |
| 66 | IgM deficiency (HP:0002850) | 2.04761060 |
| 67 | Hypoglycemic seizures (HP:0002173) | 2.01963258 |
| 68 | Type I transferrin isoform profile (HP:0003642) | 2.01796808 |
| 69 | Ulnar bowing (HP:0003031) | 2.01263854 |
| 70 | Petechiae (HP:0000967) | 2.01136945 |
| 71 | IgG deficiency (HP:0004315) | 2.00982102 |
| 72 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.00959158 |
| 73 | Vaginal fistula (HP:0004320) | 1.99797176 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 1.99073075 |
| 75 | Basal ganglia calcification (HP:0002135) | 1.97749825 |
| 76 | Abnormality of the ileum (HP:0001549) | 1.97074167 |
| 77 | Ectopic kidney (HP:0000086) | 1.96375224 |
| 78 | Unilateral renal agenesis (HP:0000122) | 1.95598863 |
| 79 | Xanthomatosis (HP:0000991) | 1.95241234 |
| 80 | Bicornuate uterus (HP:0000813) | 1.88415868 |
| 81 | Mitral stenosis (HP:0001718) | 1.88142150 |
| 82 | Facial cleft (HP:0002006) | 1.87972777 |
| 83 | Complement deficiency (HP:0004431) | 1.87071640 |
| 84 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.86434150 |
| 85 | Absent epiphyses (HP:0010577) | 1.86434150 |
| 86 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.86417259 |
| 87 | Fragile skin (HP:0001030) | 1.86286386 |
| 88 | Breast hypoplasia (HP:0003187) | 1.86092562 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 1.85920744 |
| 90 | Aplastic anemia (HP:0001915) | 1.85762244 |
| 91 | Osteomalacia (HP:0002749) | 1.84272948 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 1.82120066 |
| 93 | Pulmonary fibrosis (HP:0002206) | 1.81314873 |
| 94 | Soft skin (HP:0000977) | 1.80829081 |
| 95 | Hyperglycinemia (HP:0002154) | 1.78109416 |
| 96 | Missing ribs (HP:0000921) | 1.78012305 |
| 97 | Renal duplication (HP:0000075) | 1.77829288 |
| 98 | Abnormality of macrophages (HP:0004311) | 1.77783033 |
| 99 | Recurrent skin infections (HP:0001581) | 1.77168961 |
| 100 | Periauricular skin pits (HP:0100277) | 1.76660383 |
| 101 | Preauricular pit (HP:0004467) | 1.76660383 |
| 102 | Abnormality of magnesium homeostasis (HP:0004921) | 1.76487898 |
| 103 | Hypomagnesemia (HP:0002917) | 1.76130708 |
| 104 | Short middle phalanx of the 5th finger (HP:0004220) | 1.76012533 |
| 105 | Cheilitis (HP:0100825) | 1.75485474 |
| 106 | Abnormal delivery (HP:0001787) | 1.74897687 |
| 107 | Abnormality of carpal bone ossification (HP:0006257) | 1.74622385 |
| 108 | Beaking of vertebral bodies (HP:0004568) | 1.74459022 |
| 109 | Mesomelia (HP:0003027) | 1.74134833 |
| 110 | Partial duplication of thumb phalanx (HP:0009944) | 1.72729012 |
| 111 | Enlarged kidneys (HP:0000105) | 1.72598207 |
| 112 | Abnormality of T cell physiology (HP:0011840) | 1.72365199 |
| 113 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.71992698 |
| 114 | Abnormality of the renal collecting system (HP:0004742) | 1.70636578 |
| 115 | Short nail (HP:0001799) | 1.70147249 |
| 116 | Abnormal lung lobation (HP:0002101) | 1.70138246 |
| 117 | Myelodysplasia (HP:0002863) | 1.69977306 |
| 118 | Rough bone trabeculation (HP:0100670) | 1.69032296 |
| 119 | Granulocytopenia (HP:0001913) | 1.68448970 |
| 120 | Vasculitis (HP:0002633) | 1.68327608 |
| 121 | Double outlet right ventricle (HP:0001719) | 1.68257068 |
| 122 | Congenital malformation of the right heart (HP:0011723) | 1.68257068 |
| 123 | Abnormality of the preputium (HP:0100587) | 1.68227146 |
| 124 | Partial duplication of the phalanx of hand (HP:0009999) | 1.67791692 |
| 125 | Absent thumb (HP:0009777) | 1.67791485 |
| 126 | Abnormality of T cells (HP:0002843) | 1.67551934 |
| 127 | True hermaphroditism (HP:0010459) | 1.67549528 |
| 128 | Recurrent pneumonia (HP:0006532) | 1.66402497 |
| 129 | Abnormality of the calcaneus (HP:0008364) | 1.66130881 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.65699155 |
| 131 | Cervical subluxation (HP:0003308) | 1.65653492 |
| 132 | Hypophosphatemic rickets (HP:0004912) | 1.65418975 |
| 133 | Amaurosis fugax (HP:0100576) | 1.65397353 |
| 134 | Increased serum pyruvate (HP:0003542) | 1.65097991 |
| 135 | Gingivitis (HP:0000230) | 1.64920299 |
| 136 | Lymphoma (HP:0002665) | 1.64440967 |
| 137 | Prominent metopic ridge (HP:0005487) | 1.63428410 |
| 138 | Hepatoblastoma (HP:0002884) | 1.63347842 |
| 139 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.63121845 |
| 140 | Rectal prolapse (HP:0002035) | 1.62208849 |
| 141 | Focal segmental glomerulosclerosis (HP:0000097) | 1.61667997 |
| 142 | Bifid tongue (HP:0010297) | 1.61413460 |
| 143 | Duplication of thumb phalanx (HP:0009942) | 1.60879569 |
| 144 | Slender long bone (HP:0003100) | 1.59787434 |
| 145 | Pterygium (HP:0001059) | 1.59287137 |
| 146 | Patent foramen ovale (HP:0001655) | 1.58656025 |
| 147 | Cholecystitis (HP:0001082) | 1.57886620 |
| 148 | Abnormal gallbladder physiology (HP:0012438) | 1.57886620 |
| 149 | Concave nail (HP:0001598) | 1.57765749 |
| 150 | Occipital encephalocele (HP:0002085) | 1.57606580 |
| 151 | Abnormality of the duodenum (HP:0002246) | 1.57525949 |
| 152 | Myopathic facies (HP:0002058) | 1.57064652 |
| 153 | Recurrent lower respiratory tract infections (HP:0002783) | 1.56564382 |
| 154 | Abnormal number of incisors (HP:0011064) | 1.56491494 |
| 155 | Bone marrow hypocellularity (HP:0005528) | 1.56139046 |
| 156 | Abnormality of eosinophils (HP:0001879) | 1.56071496 |
| 157 | Decreased skull ossification (HP:0004331) | 1.55849168 |
| 158 | Delayed cranial suture closure (HP:0000270) | 1.55834514 |
| 159 | Sparse eyelashes (HP:0000653) | 1.55567620 |
| 160 | Rectal fistula (HP:0100590) | 1.54907418 |
| 161 | Rectovaginal fistula (HP:0000143) | 1.54907418 |
| 162 | Multiple enchondromatosis (HP:0005701) | 1.54476261 |
| 163 | Clubbing of toes (HP:0100760) | 1.54351862 |
| 164 | Abnormal tarsal ossification (HP:0008369) | 1.54262776 |
| 165 | Duplicated collecting system (HP:0000081) | 1.54220846 |
| 166 | Abnormal glycosylation (HP:0012345) | 1.53570550 |
| 167 | Spontaneous abortion (HP:0005268) | 1.53416767 |
| 168 | Entropion (HP:0000621) | 1.52509170 |
| 169 | Proximal tubulopathy (HP:0000114) | 1.51711110 |
| 170 | Alacrima (HP:0000522) | 1.51684953 |
| 171 | Neonatal short-limb short stature (HP:0008921) | 1.50586840 |
| 172 | Delayed CNS myelination (HP:0002188) | 1.50403604 |
| 173 | Horseshoe kidney (HP:0000085) | 1.46675574 |
| 174 | Bifid scrotum (HP:0000048) | 1.46477250 |
| 175 | Hyperphosphaturia (HP:0003109) | 1.44811460 |
| 176 | Facial shape deformation (HP:0011334) | 1.44350029 |
| 177 | Potter facies (HP:0002009) | 1.44350029 |
| 178 | Abnormality of the nasal septum (HP:0000419) | 1.44333162 |
| 179 | Impaired pain sensation (HP:0007328) | 1.43516429 |
| 180 | Abnormality of pain sensation (HP:0010832) | 1.43516429 |
| 181 | Abnormality of complement system (HP:0005339) | 1.43360068 |
| 182 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.43333857 |
| 183 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.43333857 |
| 184 | Increased nuchal translucency (HP:0010880) | 1.42527326 |
| 185 | Shallow orbits (HP:0000586) | 1.39402166 |
| 186 | Stage 5 chronic kidney disease (HP:0003774) | 1.39148897 |
| 187 | Turricephaly (HP:0000262) | 1.38947474 |
| 188 | Intrahepatic cholestasis (HP:0001406) | 1.38409732 |
| 189 | Hyperextensible skin (HP:0000974) | 1.38014164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.42674568 |
| 2 | TESK1 | 3.81500521 |
| 3 | SRPK1 | 3.80625751 |
| 4 | TESK2 | 3.42792544 |
| 5 | EIF2AK1 | 3.28690580 |
| 6 | PIM2 | 3.02202387 |
| 7 | BUB1 | 2.64141935 |
| 8 | NME2 | 2.48430455 |
| 9 | LIMK1 | 2.37799573 |
| 10 | MAP3K14 | 2.36379202 |
| 11 | VRK2 | 2.31009295 |
| 12 | ZAK | 2.09595593 |
| 13 | BLK | 2.07114751 |
| 14 | TXK | 2.03270447 |
| 15 | FGFR2 | 1.96596392 |
| 16 | STK16 | 1.91913286 |
| 17 | IRAK3 | 1.91394016 |
| 18 | ZAP70 | 1.84467627 |
| 19 | PLK4 | 1.81814514 |
| 20 | WNK4 | 1.75958667 |
| 21 | NEK1 | 1.72427872 |
| 22 | IKBKB | 1.69038884 |
| 23 | ERBB3 | 1.65896162 |
| 24 | IRAK4 | 1.65608957 |
| 25 | RPS6KA4 | 1.65282704 |
| 26 | JAK3 | 1.62533272 |
| 27 | BCKDK | 1.59297217 |
| 28 | SIK3 | 1.57682499 |
| 29 | LATS1 | 1.55845525 |
| 30 | MAP4K1 | 1.55691615 |
| 31 | CDC7 | 1.51204480 |
| 32 | ICK | 1.49345217 |
| 33 | ILK | 1.47008263 |
| 34 | FGFR4 | 1.45370109 |
| 35 | EIF2AK3 | 1.42954508 |
| 36 | EEF2K | 1.40289278 |
| 37 | PTK2 | 1.37292068 |
| 38 | EPHA2 | 1.36996881 |
| 39 | PDGFRA | 1.36732348 |
| 40 | PASK | 1.35921798 |
| 41 | EIF2AK2 | 1.35649953 |
| 42 | FLT3 | 1.35357722 |
| 43 | WEE1 | 1.35052114 |
| 44 | CHUK | 1.31556725 |
| 45 | STK38L | 1.31276258 |
| 46 | BMPR2 | 1.31150749 |
| 47 | ACVR1B | 1.26919838 |
| 48 | MAP3K11 | 1.25230374 |
| 49 | PKN2 | 1.20958139 |
| 50 | TBK1 | 1.20653841 |
| 51 | PIM1 | 1.20498243 |
| 52 | CDK7 | 1.19518835 |
| 53 | IKBKE | 1.18716777 |
| 54 | TGFBR1 | 1.14407074 |
| 55 | PRKD3 | 1.14086897 |
| 56 | TLK1 | 1.13383790 |
| 57 | NEK9 | 1.12795365 |
| 58 | SMG1 | 1.10785360 |
| 59 | MET | 1.08619946 |
| 60 | TRPM7 | 1.08535560 |
| 61 | TEC | 1.07620070 |
| 62 | FGFR1 | 1.07112946 |
| 63 | PBK | 1.03439756 |
| 64 | ATR | 1.01021537 |
| 65 | ERBB4 | 1.00213716 |
| 66 | MAP4K2 | 0.99984398 |
| 67 | NTRK3 | 0.99982690 |
| 68 | LATS2 | 0.98759323 |
| 69 | KDR | 0.98725993 |
| 70 | MAP2K6 | 0.97679661 |
| 71 | MAP3K12 | 0.95742989 |
| 72 | TYK2 | 0.95741368 |
| 73 | EPHB2 | 0.94503033 |
| 74 | MAP3K2 | 0.93393528 |
| 75 | WNK3 | 0.92509951 |
| 76 | BTK | 0.92291413 |
| 77 | TAF1 | 0.87409444 |
| 78 | BMPR1B | 0.87032456 |
| 79 | FRK | 0.86290017 |
| 80 | PHKG2 | 0.86229915 |
| 81 | PHKG1 | 0.86229915 |
| 82 | PNCK | 0.85970373 |
| 83 | CDK12 | 0.85515657 |
| 84 | PLK1 | 0.85222635 |
| 85 | NUAK1 | 0.84579632 |
| 86 | BRSK2 | 0.84549661 |
| 87 | MYLK | 0.83170456 |
| 88 | PIK3CG | 0.82551267 |
| 89 | YES1 | 0.80401521 |
| 90 | MKNK1 | 0.80209890 |
| 91 | CSNK1G1 | 0.79169029 |
| 92 | STK4 | 0.77626985 |
| 93 | MELK | 0.76732358 |
| 94 | MKNK2 | 0.76011109 |
| 95 | PAK2 | 0.74423490 |
| 96 | NTRK1 | 0.73404143 |
| 97 | STK38 | 0.73344390 |
| 98 | MARK3 | 0.72583121 |
| 99 | PAK4 | 0.72260274 |
| 100 | PDK2 | 0.71187763 |
| 101 | ADRBK2 | 0.69155851 |
| 102 | AURKB | 0.66488205 |
| 103 | MAPK11 | 0.66486772 |
| 104 | TRIM28 | 0.66461724 |
| 105 | AKT2 | 0.66381090 |
| 106 | STK3 | 0.65333181 |
| 107 | NEK2 | 0.64979170 |
| 108 | RPS6KB2 | 0.64142667 |
| 109 | MTOR | 0.62904083 |
| 110 | CSNK1G3 | 0.62856040 |
| 111 | NLK | 0.62539654 |
| 112 | TTK | 0.61579712 |
| 113 | STK10 | 0.59411790 |
| 114 | CSNK1E | 0.57610146 |
| 115 | CHEK2 | 0.57408142 |
| 116 | EPHA4 | 0.55524808 |
| 117 | CSNK1A1L | 0.54968824 |
| 118 | CAMK1G | 0.54709031 |
| 119 | PRKAA2 | 0.54237998 |
| 120 | TAOK2 | 0.53949399 |
| 121 | VRK1 | 0.53625209 |
| 122 | GRK1 | 0.53378556 |
| 123 | ATM | 0.53260341 |
| 124 | BRAF | 0.51847568 |
| 125 | CDK8 | 0.51769031 |
| 126 | SYK | 0.51315787 |
| 127 | TSSK6 | 0.51182430 |
| 128 | LYN | 0.51124919 |
| 129 | PRKAA1 | 0.50893201 |
| 130 | IRAK1 | 0.50810455 |
| 131 | CDK9 | 0.50589819 |
| 132 | KIT | 0.50577111 |
| 133 | MOS | 0.50377232 |
| 134 | CDK1 | 0.50019334 |
| 135 | PLK2 | 0.48989516 |
| 136 | DAPK3 | 0.48282504 |
| 137 | DDR2 | 0.47005906 |
| 138 | GSK3A | 0.46999512 |
| 139 | MAPKAPK3 | 0.46890313 |
| 140 | INSRR | 0.46782231 |
| 141 | DYRK3 | 0.44330802 |
| 142 | JAK1 | 0.44094228 |
| 143 | PLK3 | 0.42790789 |
| 144 | CSNK2A1 | 0.39112466 |
| 145 | MUSK | 0.37940701 |
| 146 | EPHA3 | 0.37629865 |
| 147 | MAP2K3 | 0.36560713 |
| 148 | CHEK1 | 0.34805234 |
| 149 | BRSK1 | 0.34189103 |
| 150 | ABL2 | 0.33993670 |
| 151 | NME1 | 0.33887936 |
| 152 | ITK | 0.33564056 |
| 153 | MAP3K8 | 0.33152449 |
| 154 | AURKA | 0.33040185 |
| 155 | MAP3K3 | 0.32989104 |
| 156 | DYRK2 | 0.32826752 |
| 157 | LCK | 0.32319037 |
| 158 | MAPKAPK2 | 0.31601952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.36920466 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.77280991 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 2.51430811 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.45836168 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.43042094 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.40901675 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.34895667 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.13218347 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07867269 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.04007818 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01866791 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 1.99817162 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.98749970 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96951009 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.93722978 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.92653980 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.91081227 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.87118061 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.86069204 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85653242 |
| 21 | Spliceosome_Homo sapiens_hsa03040 | 1.81021861 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.77465363 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.73909607 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.71769607 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.70269501 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.70092075 |
| 27 | RNA transport_Homo sapiens_hsa03013 | 1.69148360 |
| 28 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.68302165 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.64818495 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64771164 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.64194347 |
| 32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.60787724 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60442925 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.58310351 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.58171618 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56018013 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.54202297 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53345363 |
| 39 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.51730624 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50715857 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.49112140 |
| 42 | Cell cycle_Homo sapiens_hsa04110 | 1.48349848 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45753238 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45414242 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.44035354 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.44009284 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43985819 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43059121 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.42900230 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40906158 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.39118181 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 1.38124437 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.37708921 |
| 54 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.35858241 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34635479 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34441996 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.33818767 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32427930 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.29294989 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29050389 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28729839 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27344237 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26976390 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 1.26734108 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25886621 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.25227408 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25045951 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24104545 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23387419 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22946329 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 1.22876511 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22504532 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.21571942 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20619998 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20430113 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19953380 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18549420 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.18034127 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.17846482 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.17055223 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 1.15952173 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12657904 |
| 83 | Malaria_Homo sapiens_hsa05144 | 1.11942479 |
| 84 | Influenza A_Homo sapiens_hsa05164 | 1.11534422 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10289792 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09011138 |
| 87 | Asthma_Homo sapiens_hsa05310 | 1.08574776 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.05894832 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05452879 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04391381 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03817945 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 1.03589990 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03469846 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03375073 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02613643 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00662543 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00481788 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99149373 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99070437 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98516289 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98357459 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98284281 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98235924 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95525574 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90365555 |
| 106 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88170830 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84945840 |
| 108 | Purine metabolism_Homo sapiens_hsa00230 | 0.80382760 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.80223761 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.79029347 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77063801 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76601318 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75493430 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75074065 |
| 115 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.75052573 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74158909 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.74104857 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73318196 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.72855021 |
| 120 | Bile secretion_Homo sapiens_hsa04976 | 0.70406027 |
| 121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70162803 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68297998 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67770750 |
| 124 | Tuberculosis_Homo sapiens_hsa05152 | 0.64306901 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64272018 |
| 126 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.63005998 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.60821162 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58551815 |
| 129 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57587378 |
| 130 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57239229 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57149706 |
| 132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56956401 |
| 133 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56260985 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53422727 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.53369176 |
| 136 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.52879948 |
| 137 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52096755 |
| 138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51317985 |
| 139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49839130 |
| 140 | ABC transporters_Homo sapiens_hsa02010 | 0.49568534 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48809280 |
| 142 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48607858 |
| 143 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48211556 |
| 144 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48134956 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45851631 |
| 146 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45135653 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44729322 |
| 148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44264014 |
| 149 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43421683 |
| 150 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42594399 |
| 151 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41830657 |
| 152 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41785367 |
| 153 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38896300 |
| 154 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37944291 |
| 155 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36965180 |
| 156 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36809378 |
| 157 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36734659 |
| 158 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36732448 |
| 159 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36703901 |
| 160 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36139840 |
| 161 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34867718 |
| 162 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33707758 |
| 163 | Adherens junction_Homo sapiens_hsa04520 | 0.32465125 |
| 164 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30859862 |
| 165 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29670449 |
| 166 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29450174 |
| 167 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27547831 |
| 168 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27371154 |
| 169 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26985809 |
| 170 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.26005057 |

